Physician
Pain Management Consultants, PA
Pain Management Consultants, PA was paid $11K by Medicaid between Jan 2018 and Dec 2019, across 11 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 95% of everything it billed.
33Billing provider infoPAIN MANAGEMENT CONSULTANTS, PA
AUSTIN, TX 78751
AUSTIN, TX 78751
33aNPI1053526343assigned 05/11/2007
33bProvider typeInterventional Pain Medicine Physician
28Total paid$11K
24GClaims3,957
24DCodes billed11
24AFirst – last monthJan 2018 – Dec 2019
Compared with peers
Next to other Interventional Pain Medicine Physician providers in Texas
Rank by total paid#15 of 27
Median peer was paid$12K
This provider vs. median0.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,875 | $4K | |
| 2019 | 2,082 | $6K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 95% | 1,002 | 969 | $10K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 5.2% | 27 | 26 | $557.94 |
| 1036F | 0% | 515 | 500 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 35 | 33 | $0.00 |
| G8730 | Pain assessment documented as positive using a standardized tool and a follow-up plan is documented | 0% | 832 | 809 | $0.00 |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 0% | 301 | 296 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 328 | 317 | $0.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 829 | 806 | $0.00 |
| 4004F | 0% | 12 | 12 | $0.00 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 0% | 64 | 64 | $0.00 |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 12 | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHARO, JOEL (ADMINISTRATOR)